Profile of Human Milk Oligosaccharides and FUT2 Polymorphism of Mothers in Indonesia

Profile of Human Milk Oligosaccharides and FUT2 Polymorphism of Mothers in Indonesia: A Study on the Association Between Maternal Genotype-Phenotype Secretor Status and Short Chain Fatty Acid Profile Based on the Mother-Infant Genotype Pair

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05156255

Enrollment

120

Registered

2021-12-14

Start date

2021-12-01

Completion date

2023-04-14

Last updated

2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastfeeding, Exclusive

Keywords

Human Milk Oligosaccharide, Short Chain Fatty Acid

Brief summary

Human milk oligosaccharides (HMOs), the third most abundant constituent of breastmilk, are known to have beneficial effects on infant immunity. Maternal genetic polymorphisms cause HMO variability. The FUT2 gene determines the secretor status, whereas the FUT3 gene is responsible for the expression of Lewis fucosyltransferase. Therefore, breastmilk can be classified to four groups according to the variation. To date, this variability has not been investigated in Indonesia. This study aims to evaluate the association between FUT2 gene polymorphism and 2'-Fucosyllactose (2'-FL) secretor phenotype. In addition, infant FUT2 gene polymorphism and short chain fatty acid (SCFA) profile from stool samples are also analysed.

Detailed description

Eligible mother-infant pairs are explained about this study. Those willing to participate in this study are asked for written informed consent. Mothers are interviewed about their baseline characteristics, family pedigree, nutritional intake, and routine drug consumption. Infants are checked for their birth history. Both are measured for weight and height. Four specimens are collected from the subjects: 1. Mother 1. Breastmilk Breastmilk is expressed at 8-11 AM to avoid variability due to circadian rhythm. One breast is emptied, 30 mL of breastmilk is stored in a sterile container, and the rest is returned for feeding. Breastmilk is divided to five 2-mL cryovials and stored in a -80°C freezer. The remaining is stored in a -20°C freezer. 2. Blood Blood samples (3 mL) are collected for DNA extraction. 2. Infant 1. Buccal cells Buccal swab kits are used to obtain samples for DNA extraction. 2. Stool Stool specimens are collected at the age of four weeks in a sterile container and stored in a -80°C storage before short chain fatty acid profile analysis.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

2 Weeks to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Mother 1. Minimum of 18 years old 2. With term infants aged 2-5 weeks 3. Exclusively breastfeed 4. Healthy condition 5. Agree to participate and sign the informed consent * Infant 1. Infant with mother who fulfil the eligibility criteria

Exclusion criteria

* Mother 1. Has a Caucasian ancestor in two generations above 2. Infant has multiple congenital anomalies * Infant 1. Has ever received antibiotics

Design outcomes

Primary

Measure	Time frame	Description
Human milk oligosaccharides profile of Indonesian mothers	1 day	The concentration of 19 HMOs will be measured using high performance anion exhange chromatography with pulsed amperometric detection (HPAEC-PAD).
Proportion of FUT2 secretor genotype of mothers based on single nucleotide polymorphism (SNP) rs601338	1 day	Sequencing of coding sequence (exon 2) of FUT2 gene will be performed using a previously known outer primer from the study by Lefebvre, et al (2020). The results will be aligned with database from www.ncbi.nlm.nih.gov to find the proportion of rs601338 among mothers.
Association between rs601338 FUT2 secretor genotype and 2'-FL secretor phenotype in mothers	1 day	The association between rs601338 FUT2 genotype (homozygous dominant, heterozygous, homozygous recessive) and 2'-FL concentration will be analysed using ANOVA test.

Secondary

Measure	Time frame	Description
Novel FUT2 polymorphism in Indonesian mothers	1 day	The sequencing result of exon 2 in the FUT2 gene will be aligned with database from www.ncbi.nlm.nih.gov to find novel variants. Additional information regarding existing variants will be browsed using the same database. The allele frequency of new variants will be calculated to determine new SNP.
Profile of infant stool short chain fatty acid based on mother-infant FUT2 genotype pairs	1 day	The concentration of total short chain fatty acid, acetate, propionate, and butyrate in infant's stool will be measured using gas chromatography-mass spectrometry (GC-MS). Difference in the concentration between four mother-infant genotype pairs will be analysed using ANOVA test.
Proportion of FUT2 secretor genotype of infants based on single nucleotide polymorphism (SNP) rs601338	1 day	Sequencing of coding sequence (exon 2) of FUT2 gene will be performed using a previously known outer primer from the study by Lefebvre, et al (2020). The results will be aligned with database from www.ncbi.nlm.nih.gov to find the proportion of rs601338 among infants.
Novel FUT2 polymorphism in infant	1 day	The sequencing result of exon 2 FUT2 will be aligned with database from www.ncbi.nlm.nih.gov to find novel variants. Additional information regarding existing variants will be browsed using the same database. The allele frequency of new variants will be calculated to determine new SNP.

Countries

Indonesia

Outcome results